Clinical Measures of Muscular Strength in Individuals Treated for - - PowerPoint PPT Presentation

clinical measures of
SMART_READER_LITE
LIVE PREVIEW

Clinical Measures of Muscular Strength in Individuals Treated for - - PowerPoint PPT Presentation

Clinical Measures of Muscular Strength in Individuals Treated for Breast Cancer Genesis Research Summit June 3, 2014 Christine H. Beuthin, PT , DPT , GCS, CLT Session Objectives 1. Provide evidence of strength impairments in breast cancer


slide-1
SLIDE 1

Clinical Measures of Muscular Strength in Individuals Treated for Breast Cancer

Genesis Research Summit June 3, 2014 Christine H. Beuthin, PT , DPT , GCS, CLT

slide-2
SLIDE 2

Session Objectives

  • 1. Provide evidence of strength impairments in breast

cancer patients secondary to cancer treatments.

  • 2. Identify strength assessment techniques with sound

psychometric properties used with breast cancer patients.

  • 3. Recognize the role of consistency in outcome

measures to assess patient status and demonstrate intervention effectiveness in individual and patient groups.

slide-3
SLIDE 3

Operational Definition

  • Muscular strength
  • Force generation by muscles
  • The ability to resist being moved or give way to a

force

slide-4
SLIDE 4

Evidence of Impairment in BC

Acute

  • Strength
  • Elevation strength: up to 20% deficit compared to

the contralateral limb

  • Strength deficits up to 27% compared to age-

matched controls

Blomqvist Acta Oncol 2004, Harrington J Ca Surviv 2011, Hayes Br Ca Res Treat 2005

Long Term

  • Strength
  • 8% loss in shoulder abduction strength compared to

pre-operative status

  • 7-18% for shoulder elevation strength deficits
slide-5
SLIDE 5

EDGE: Evaluation Database to Guide Effectiveness

  • American Physical Therapy Association
  • Oncology Section
  • Breast Cancer EDGE Taskforce
slide-6
SLIDE 6

Oncology Section Task Force on Breast Cancer Outcomes:

Muscular Strength

Originally presented: February 2014

  • Mary I. Fisher, PT

, PhD, OCS, CLT

  • Claire Davies, PT

, PhD, CLT-LANA

  • Cindy Pfalzer, PT

, PhD, FACSM, FAPTA

  • Chris Beuthin, PT

, DPT , GCS, CLT

  • Brittany Zoll, DPT
  • Genevieve Colon, SPT
slide-7
SLIDE 7

Strength Outcome Measures

  • Systematic Review used to assess:
  • Reliability
  • Validity
  • Sensitivity to Change
  • Clinical Utility
slide-8
SLIDE 8

Search Strategy

Databases and Sites Searched

(Total hits = 471 including repeats)

Search Terms/Strings (hits with potential for review)

 Google Scholar  Ovid  Pubmed/Medline  CINAHL  Sports Discus  Web of Science  Cochrane Review  PEDro  Academic Search  Strength measure/measurement/ test  Manual muscle test  Psychometric properties/clinimetrics  Power  Energy

slide-9
SLIDE 9

Article Selection

Inclusion Criteria

  • Strength measures
  • Strength tools
  • Adults, preferably female (human subjects)
  • English language
  • Clinically feasible methods
  • Psychometric properties reported
slide-10
SLIDE 10

Article Selection

Exclusion Criteria

  • Non-clinical measures of strength
  • Functional mobility measures (TUG, STS,

Gait speed, etc.)

slide-11
SLIDE 11

Consensus Selection

  • Final number of articles reviewed for

inclusion: 29

  • Review of testing methods – 16 articles
  • 13 removed as not meeting criteria (lacking

psychometric data, not in compared in comparable population, lacked clinical utility)

  • Each outcome measure reviewed independently

and rated by two reviewers

  • If outcome measure rating in disagreement,

discussion with 4 reviewers until agreement

  • btained
slide-12
SLIDE 12

Breast Cancer EDGE Rating Scale

Oncolog

  • logy EDGE

4 Highly Recommend Highly recommended; the outcome measure has excellent psychometric properties and clinical utility; the measure has been used in research on individuals with or post breast cancer. 3 Recommend Recommended; the outcome measure has good psychometric properties and good clinical utility; no published evidence that the measure has been applied to research on individuals with or post breast cancer. 2A Unable to Recommend at this time Unable to recommend at this time; there is insufficient information to support a recommendation of this

  • utcome measure; the measure has been used in research
  • n individuals with or post breast cancer.

2B Unable to Recommend at this time Unable to recommend at this time; there is insufficient information to support a recommendation of this

  • utcome measure; no published evidence that the

measure has been applied to research on individuals with

  • r post breast cancer.

1 Do not Recommend Poor psychometrics &/or poor clinical utility (time, equipment, cost, etc.)

slide-13
SLIDE 13

Outcome Measures Selected

  • Manual Muscle Testing
  • 1 RM Strength Testing
  • Hand-grip Strength
  • Hand-held Dynamometry
slide-14
SLIDE 14

Manual Muscle Testing

6 Point Scale 0 = no contraction 1 = flicker of contraction 2 = active movement with gravity eliminated 3 = active movement against gravity 4 = active movement against gravity and resistance 5 = normal power

slide-15
SLIDE 15

Final Analysis: MMT

  • No studies yielded a rating 3 or 4
  • No studies with methodology designed

specifically for the breast cancer population

  • High clinical utility
  • Reliability Poor
  • Rating 2B = unable to recommend
slide-16
SLIDE 16

1 RM Strength Testing

  • 1RM defined as the heaviest load that can be

moved over a specific range of motion with correct performance one time. (Pereira 2003)

  • Psychometric properties have not been

examined in upper extremity activities

  • Further research is needed, especially in BCS
  • Rating 2B = unable to recommend at this time
slide-17
SLIDE 17

Hand Grip Strength

  • Often used as a proxy for overall functional

health

  • Measured with objective tool
slide-18
SLIDE 18

Final Analysis: Hand Grip Strength

  • No studies rated 4 (Highly Recommended)
  • Has been used in a study of breast cancer

survivors

  • Good but incomplete psychometric properties
  • Clinical Utility excellent: equipment easy to

use, staff training simple

  • Need studies examining psychometrics in BCS
  • Rating 3 = recommended
slide-19
SLIDE 19

Hand Held Dynamometry

slide-20
SLIDE 20

Hand Held Dynamometry

  • Easy to use clinically
  • Methodology similar to MMT
  • Normative data available
slide-21
SLIDE 21

Final Analysis for HHD

  • No studies yielded a rating of 4 (Highly

Recommended)

  • Not utilized in BC population
  • Good psychometric qualities: reliability
  • Clinically feasible
  • Rating 3 = recommended
slide-22
SLIDE 22

Muscle Strength

Outcome Measure Rating Manual Muscle Testing 2B – Unable to recommend 1 RM Strength Testing 2B – Unable to recommend Grip Strength - Dynamometry 3 - Recommended Hand Held Dynamometry 3 – Recommended

Limitations of Recommended Measures:

  • Lack of validation in the breast cancer population: more research

needed

  • Lack of MCID values: change of measure considered clinically
  • relevant to patient
  • Lack of Hand Held Dynamometers in many clinics
slide-23
SLIDE 23

Impact on Patient Care

  • Physical therapists can use the two

recommended outcome measures to show the before and after results of treatment

  • This is motivational for patient as well as
  • bjective evidence of improvement in

documentation reviewed by payer sources

slide-24
SLIDE 24

24

Questions? Thank you !